Clinical Applications of Mifepristone (RU486) and Other Antiprogestins

Assessing the Science and Recommending a Research Agenda

AvInstitute of Medicine,Committee on Antiprogestins: Assessing the Science

Häftad, Engelska, 1993

1 397 kr

Tillfälligt slut

Beskrivning

Mifepristone (RU486), the first clinically available antiprogestin, has generated great interest since its discovery in the early 1980s. Today, it is recognized that mifepristone, along with other antiprogestins, has a potentially significant therapeutic role in human health and disease, with likely applicability to a variety of pregnancy-related conditions (e.g., management of labor) and to contraception, endometriosis, and cancer, among others. But because mifepristone has been studied and used most widely as a means of nonsurgical abortion, political issues have thus far limited research on the drug and prevented its introduction into the U.S. market. This book provides an unbiased evaluation of current knowledge about both the fundamental nature of antiprogestins as well as their possible use in treating numerous diseases and conditions, and it contains recommendations for future research.

Produktinformation

Utgivningsdatum:1993-01-01
Mått:152 x 229 x 19 mm
Vikt:485 g
Format:Häftad
Språk:Engelska
Antal sidor:304
Förlag:National Academies Press
ISBN:9780309049498

Utforska kategorier

Gynekologi och obstetrik inom Medicin
Farmakologi inom Medicin

Mer om författaren

Molla S. Donaldson, Laneta Dorflinger, Sarah S. Brown, and Leslie Z. Benet, Editors; Committee on Antiprogestins: Assessing the Science, Institute of Medicine

Innehållsförteckning

1 Front Matter; 2 Summary; 3 INtroduction; 4 Uses of Antiprogestins: The Reproductive Cycle (Part I); 5 Uses of Antiprogestins: The Reproductive Cycle (Part II); 6 Other Therapeutic Uses of Antiprogestins; 7 Antiglucocorticoid Effects of Antiprogestins; 8 Animals as Models for Studying Antiprogestins; 9 Appendix A: Agenda fr the IOM Workshop 'Antiprogestins: Assessing the Science'; 10 Appendix B: Background Papers and Presentations (In Order of Presentation at IOM Workshop); 11 B1. 1993: RU 486--A Decade on Today and Tomorrow; 12 B2. Overview and Background: Mechanism of Action of Antiprogestins; 13 B3. The Use of Antiprogestins in the Reproductive Cycle; 14 B4. Potential Contraceptive Effects of Antigestogens; 15 B5. Use of Antiprogestins Before 63 Days of Amenorrhea; 16 B6. Uses of Antiprogestins After 63 Days of Amenorrhea; 17 B7. Comments on Session II; 18 B8. Use of Antiprogestins in the Management of Endometriosis and Leiomyoma; 19 B9. Antiprogestins and the Treatment of Breast Cancer; 20 B10. Uses of RU 486 as an Antiglucocoticoid; 21 B11. Primate Models for the Study of Antiprogestins in Reproductive Medicine; 22 B12. ANtiprogestogens: Perspectives from a Global Research Program; 23 Appendix C: Observers at the Workshop on Antiprogestins; 24 Index

Mer från samma författare

Examining the Health Disparities Research Plan of the National Institutes of Health

Institute of Medicine, Board on Health Sciences Policy, Committee on the Review and Assessment of the NIH's Strategic Research Plan and Budget to Reduce and Ultimately Eliminate Health Disparities, Monique B. Williams, Faith Mitchell, Gerald E. Thomson

Häftad, 2006

800 kr

Nursing and Nursing Education

Institute of Medicine, Division of Health Care Services

Häftad, 1983

1 816 kr

Bereavement

Institute of Medicine, Committee for the Study of Health Consequences of the Stress of Bereavement

Häftad, 1984

2 065 kr

New Vaccine Development

Institute of Medicine, Board on Population Health and Public Health Practice, Division of Health Promotion and Disease Prevention, Division of International Health

Häftad, 1986

1 994 kr

Social and Built Environment in an Older Society

Institute of Medicine, Committee on an Aging Society

Häftad, 1988

1 806 kr

Physician Staffing for the VA

Institute of Medicine, Committee to Develop Methods Useful to the Department of Veteran Affairs in Estimating Its Physician Requirements, Joseph Lipscomb

Häftad, 1991

1 299 kr